Reperfusion injury intensifies the adaptive human T cell alloresponse in a human-mouse chimeric artery model

T Yi, B Fogal, Z Hao, Z Tobiasova, C Wang… - … , and vascular biology, 2012 - Am Heart Assoc
T Yi, B Fogal, Z Hao, Z Tobiasova, C Wang, DA Rao, RS Al-Lamki, NC Kirkiles-Smith…
Arteriosclerosis, thrombosis, and vascular biology, 2012Am Heart Assoc
Objective—Perioperative nonimmune injuries to an allograft can decrease graft survival. We
have developed a model for studying this process using human materials. Methods and
Results—Human artery segments were transplanted as infrarenal aortic interposition grafts
into an immunodeficient mouse host, allowed to “heal in” for 30 days, and then
retransplanted into a second mouse host. To induce a reperfusion injury, the healed-in
artery segments were incubated for 3 hours under hypoxic conditions ex vivo before …
Objective
Perioperative nonimmune injuries to an allograft can decrease graft survival. We have developed a model for studying this process using human materials.
Methods and Results
Human artery segments were transplanted as infrarenal aortic interposition grafts into an immunodeficient mouse host, allowed to “heal in” for 30 days, and then retransplanted into a second mouse host. To induce a reperfusion injury, the healed-in artery segments were incubated for 3 hours under hypoxic conditions ex vivo before retransplantation. To induce immunologic rejection, the animals receiving the retransplanted artery segment were adoptively transferred with human peripheral blood mononuclear cells or purified T cells from a donor allogeneic to the artery 1 week before surgery. To compare rejection of injured versus healthy tissues, these manipulations were combined. Results were analyzed ex vivo by histology, morphometry, immunohistochemistry, and mRNA quantitation or in vivo by ultrasound. Our results showed that reperfusion injury, which otherwise heals with minimal sequelae, intensifies the degree of allogeneic T cell–mediated injury to human artery segments.
Conclusion
We developed a new human-mouse chimeric model demonstrating interactions of reperfusion injury and alloimmunity using human cells and tissues that may be adapted to study other forms of nonimmune injury and other types of adaptive immune responses.
Am Heart Assoc